Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations

Hsp90 C-terminal domain (CTD) inhibitors are promising novel agents for cancer treatment, as they do not induce the heat shock response associated with Hsp90 N-terminal inhibitors. One challenge associated with CTD inhibitors is the lack of a co-crystallized complex, requiring the use of predicted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomašič, Tihomir, Durcik, Martina, Keegan, Bradley M., Skledar, Darja Gramec, Zajec, Živa, Blagg, Brian S. J., Bryant, Sharon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555175/
https://www.ncbi.nlm.nih.gov/pubmed/32962253
http://dx.doi.org/10.3390/ijms21186898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555175/
https://www.ncbi.nlm.nih.gov/pubmed/32962253
http://dx.doi.org/10.3390/ijms21186898

Ejemplares similares